Summary

Other Scenarios:

Buyer: King Pharmaceuticals, Inc. (KG) Last Price: 21.08 Market Cap.: 5.14B
Target: Warner Chilcott Ltd. (WCRX) Last Price: 19.52 Market Cap.: 4.89B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare 916
Biopharmaceuticals 366
Medical Devices   255
Outsourced Services   65
Manufacturing   1,190
Consumer Manufacturing   338

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 70)
  • Adrenalin Chloride Solution (Epinephrine)
  • Corgard (Nadolol)
  • Adenocard (Adenosine)
  • Procanbid (Procainamide Hydrochloride)
Target (Total: 28)
  • Doryx (Doxycycline Hyclate)
  • Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol)
  • Dovonex (Calcipotriene)
  • Taclonex (Calcipotriene/Betamethasone Dipropionate)
Buyer
  • Meridian Medical Technologies Prime ECG Electrocardiac Mapping System
  • Binodenoson
  • Meridian Medical Technologies Transtelephonic Blood Pressure Monitors
  • Meridian Medical Technologies CardioBeepers
Target
  • Moisturel

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 8)
  • sanofi-aventis (ADR) (SNY)
  • Harte-Hanks, Inc. (HHS)
  • Allscripts Healthcare Solutions, Inc. (MDRX)
  • Pain Therapeutics, Inc. (PTIE)
Target (Total: 3)
  • Bristol Myers Squibb Co. (BMY)
  • Barr Pharmaceuticals, Inc. (BRL)
  • LEO Pharma A/S
Buyer (Total: 8)
  • McKesson Corporation (MCK)
  • Cardinal Health, Inc. (CAH)
  • AmerisourceBergen Corp. (ABC)
  • Salix Pharmaceuticals, Ltd. (SLXP)
Target (Total: 4)
  • McKesson Corporation (MCK)
  • Cardinal Health, Inc. (CAH)
  • AmerisourceBergen Corp. (ABC)
  • CVS Caremark Corporation (CVS)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 2,800 985
Revenue Per Employee 739,210.9 884,933.6
Total Revenue 516.0 218.4
Total Expenses 348.2 224.4
Other Revenue 0.0 2.3
Cost of Revenue 111.5 50.6
SG&A Expense 168.3 77.9
Research & Development 32.3 7.4
Other Operating Expense 0.0 0.0
Operating Income 167.9 -6.0
Unusual Income 0.5 0.0
LT Debt to Capital 14.24 52.74
Fwd P/E 11.81 20.46
Fwd P/Rev 2.50 5.71
Book Value 2,409.7 1,323.1
Curr Portion of LTD/Cap Lease 0.0 11.2

Individual Company Summary

Focused

Buyer

Focused (): *Healthcare > Biopharmaceuticals

Target

Focused (): *Healthcare > Biopharmaceuticals > Obstetrics/Gynecology

Business Description

Buyer

King Pharmaceuticals, Inc. (King) is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The Company operates through five segments: Branded pharmaceuticals, Meridian Medical Technologies, Royalties, Contract manufacturing and other. On February 26, 2007, the Company acquired all the rights to Avinza in the United States, its territories and Canada from Ligand Pharmaceuticals Incorporated. In February 2007, King announced that the United States Food and Drug Administration approval of its manufacturing and production facility in Rochester, Michigan, for its Bicillin product line. On January 9, 2007, king obtained a license to the hemostatic products designed for use outside of catheterization and electrophysiology laboratories by Vascular Solutions, Inc. On March 1, 2006, it acquired substantially all of the assets of Allerex Laboratory LTD.

Target

Warner Chilcott Limited (Warner Chilcott) is a specialty pharmaceutical company focused on segments of the United States pharmaceutical market, women?s healthcare and dermatology. It operates two manufacturing facilities located in Fajardo, Puerto Rico and Larne, Northern Ireland. During the year ended December 31, 2006, the Company completed the acquisition of the United States sales and marketing rights to DOVONEX and obtained United States Food and Drug Administration (FDA) approval of TACLONEX.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 78.28 78.85
Operating Margin % 24.64 -17.96
Quick Ratio 2.33 0.8
Current Ratio 3.01 1.68
Coverage Ratio 0.05 4.02
Total Assets 3,333.5 3,119.6
Return on Equity % 14.68 -9.88
Return on Assets % 10.61 -4.19
Cash+ ST Inv. Per Share 3.36 0.28
Total Debt 400.0 1,487.8
Total Debt to Equity % 16.6 112.45
Total Debt to Tangible Equity % 34.11 n/a
Debt to Asset % 12.00 47.69

Product Summary

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
Ophthalmology
The Ophthalmology Subsector includes therapeutics that treat eye disorders, infections, inflammations and irritations.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
Wound Management
The Wound Management Subsector includes therapeutics that treat cuts, abrasions, and burns from trauma or diseases.
  
Medical Devices  
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
  
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
  
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
  
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
  
Radiology
The Radiology Subsector includes medical devices that generate images of internal physiology.
  
Outsourced Services  
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
  
Manufacturing  
Consumer Manufacturing  
Personal Care and Cleaning Products
Companies engaged in the manufacturing of personal care products, such as cosmetics, fragrances, skin lotion, shampoo and other toiletries; and household cleaning products, such as window/surface cleaner, and table polish.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies  
Systemic  
Anaphylactic Shock  
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that treat allergic shock by stimulating alpha and beta adrenergic receptors.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Cardiovascular System  
Heart Disorders  
Angina  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Corgard (Nadolol)
  
Arrhythmia  
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction

Buyer Products:

  • Adenocard (Adenosine)
  
Sodium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of sodium into heart muscle cells.

Buyer Products:

  • Procanbid (Procainamide Hydrochloride)
  
Heart Failure (HF)  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat the ineffective pumping of the heart by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)
  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Vascular Disorders  
Hypertension  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Corgard (Nadolol)
  
Beta Receptor Blocking Agents (Beta Blockers)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.

Buyer Products:

  • Corzide (Nadolol/Bendroflumethiazide)
  
Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Dermatology
Acne  
Vulgaris  
Antibacterial Agents  
Tetracyclines
Therapeutics that treat acne caused by bacterial infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.

Target Products:

  • Doryx (Doxycycline Hyclate)
  
Estrogens/Progestins
Therapeutics that treat acne by providing estrogen and progestin.

Target Products:

  • Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol)
  
Lesion/Scaling Disorders
Dermatoses  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that counteract or suppress inflammation by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site, as well as prevent the growth of bacteria.

Buyer Products:

  • Cortisporin (Neomycin/Polymyxin B Sulfates/Hydrocortisone Acetate) Cream/Ointment
  
Psoriasis  
Vitamin D Analogs
Therapeutics that treat psoriasis by providing vitamin D-like compounds.

Target Products:

  • Dovonex (Calcipotriene)
  
Vitamin D Analogs/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat psoriasis by providing vitamin D-like compounds and by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.

Target Products:

  • Taclonex (Calcipotriene/Betamethasone Dipropionate)
  • Taclonex Scalp Gel (Calcipotriene/Betamethasone Dipropionate)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of skin disorders in very early stages of research where no human subject is involved.

Target Products:

  • WC2063
  • Novel Narrow-Spectrum Antibacterial Tetracyclines
  • WC3018 (Topical Antibiotic)
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroesophageal Disorders  
Nausea/Vomiting  
Antiemetic Agents
Therapeutics that treat nausea or vomiting by acting locally on the hyperactive gastrointestinal wall.

Buyer Products:

  • Tigan (Trimethobenzamide Hydrochloride)
  
Liver Disorders  
Cirrhosis  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Endocrinology/Metabolism
Adrenal Gland Disorders  
Adrenocortical Insufficiency  
Synthetic Adrenocortical Steroids
Therapeutics that treat Adrenocortical Insufficiency by acting on the distal tubules of the kidney to enhance the reabsorption of sodium ions and to increase the urinary excretion of both potassium and hydrogen ions.

Buyer Products:

  • Florinef (Fludrocortisone Acetate)
  
Diabetes  
Induced Complications  
Central Diabetes Insipidus  
Antidiuretic Agents
Therapeutics that treat prevent the lose of water in the urine.

Buyer Products:

  • Pitressin (Vasopressin)
  
General Hormone Treatments
Estrogens
Therapeutics that treat hormonal disorders by providing estrogen.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  • Menest (Esterified Estrogens Tablets)

Target Products:

  • Estrace Tablet (Estradiol)
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • MRE0094 (Adenosine A2a Receptor Agonist)
  
Pituitary Gland Disorders  
Pituitary Hyperthyroidism (TSH-Induced)  
Thyroid Hormones
Hormones that affect the rate of cell metabolism and blood calcium levels.

Buyer Products:

  • Levoxyl (Levothyroxine Sodium)
  
Reproductive Disorders
Hypogonadism  
Female  
Hormonal Treatments  
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)
  
Menopause
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)

Target Products:

  • Femtrace (Estradiol Acetate)
  • Estrace Tablet (Estradiol)
  • Femring (Estradiol Acetate Vaginal Ring)
Estrogens/Progestins
Therapeutics that are mixture of two female sex hormones that are important for the development of the female reproductive system.

Target Products:

  • FEMHRT (Norethindrone Acetate/Ethinyl Estradiol)
  
Thyroid Gland Disorders  
Hyperthyroidism  
Thyroid Hormone Synthesis Inhibitors
Therapeutics that stop the production of thyroid hormones.

Buyer Products:

  • Tapazole (Methimazole)
  
Hypothyroidism  
Thyroid Hormones
Therapeutics that treat a deficiency in thyroid activity by supplementing thyroid hormones.

Buyer Products:

  • Levoxyl (Levothyroxine Sodium)
  • Triostat (Liothyronine Sodium)
  • Cytomel (Liothyronine Sodium)
  
Immunology  
Autoimmune Disorders  
Psoriasis  
Vitamin D Analogs
Therapeutics that treat a chronic autoimmune disease characterized by softening, separating, causing the shedding of the horny layer of the skin by inhibiting the proliferation of skin cells.

Target Products:

  • Dovonex (Calcipotriene)
  
Vitamin D Analogs/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat psoriasis by providing vitamin D-like compounds and by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.

Target Products:

  • Taclonex Scalp Gel (Calcipotriene/Betamethasone Dipropionate)
  • Taclonex (Calcipotriene/Betamethasone Dipropionate)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.

Target Products:

  • WC2063
  
Infectious Diseases
Bacterial
Antibacterial Agents
Broad Spectrum
Antibiotics
Aminoglycosides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.

Buyer Products:

  • Coly-Mycin M Parenteral (Colistimethate Sodium)
  
Carbacephems
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Buyer Products:

  • Lorabid (Loracarbef)
  
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Target Products:

  • Duricef (Cefadroxil)
  
Macrolides
Therapeutics that treat a wide variety of infections by inhibiting RNA-dependent bacterial protein synthesis.

Target Products:

  • ERYC (Erythromycin Delayed-Release Capsules)
  
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.

Buyer Products:

  • Penicillin G Procaine Injectable Suspension
  • Bicillin C-R/C-R 900/300/C-R Pediatric (Penicillin G Benzathine/Penicillin G Procaine Injectable Suspension)
  • Bicillin L-A/L-A Pediatric (Penicillin G Benzathine Injectable Suspension)
  
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.

Buyer Products:

  • Synercid (Quinupristin/Dalfopristin)
  
Narrow Spectrum
Dermatology  
Dermatoses  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotics)
Therapeutics that treat bacterial infections of the skin with a steroidal compound and a compound that kills or inhibits the growth of bacteria.

Buyer Products:

  • Cortisporin (Neomycin/Polymyxin B Sulfates/Hydrocortisone Acetate) Cream/Ointment
  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat specific bacterial infections by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Musculoskeletal System  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat bacterial infections of non-skeletal tissue usually involving fat, muscle, and skin by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Ophthalmology  
Ocular Infections  
Aminoglycosides/Polypeptides
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis and damaging the cell membrane.

Buyer Products:

  • Neosporin Ophthalmic (Neomycin Sulfate B/Polymyxin Sulfate B/Gramicidin) Ointment/Solution Sterile
  
Aminoglycosides/Polypeptides/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat bacterial infections of the eye by inhibiting bacterial protein synthesis, damaging the cell membrane, and suppressing the full immune response.

Buyer Products:

  • Cortisporin Opthalmic (Neomycin/Polymyxin B Sulfates/Bacitracin Zinc/Hydrocortisone) Ointment/Suspension Sterile
  
Polypeptides
Therapeutics that treat bacterial infections of the eye by damaging the cell membrane.

Buyer Products:

  • Polysporin (Bacitracin Zinc/Polymyxin B Sulfate)
  
Otolaryngology (Ear/Nose/Throat)  
External Ear Canal Infections  
Steroidal Anti-Inflammatory Drugs (SAID)/Antibacterial Agents (Antibiotic)
Therapeutics that treat bacterial infections of the external auditory canal with a steroidal compound and by killing or inhibiting the growth of microorganisms.

Buyer Products:

  • Cortisporin-TC Otic (Colistin Sulfate/Neomycin Sulfate/Thonzonium Bromide/Hydrocortisone Acetate)
  • Cortisporin Otic (Neomycin/Polymyxin B Sulfate/Hydrocortisone) Solution/Suspension Sterile
  • Coly-Mycin S Otic (Colistin Sulfate/Neomycin Sulfate/Thonzonium Bromide/Hydrocortisone Acetate)
  • Pediotic Suspension Sterile (Neomycin/Polymyxin B Sulfates/Hydrocortisone)
  
Otitis Media  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the middle ear inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Respiratory System  
Bronchitis  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Pneumonia  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Urology
Urinary Tract Infections (UTI)
Antibacterial Agents (Antibiotics)
Aminoglycosides
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by inhibiting bacterial protein synthesis.

Buyer Products:

  • Neosporin G.U. Irrigant (Neomycin Sulfate/Polymyxin B Sulfate)
  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Formaldehyde Precursors
Therapeutics that prevent bacterial infections of the urinary tract by forming formaldehyde, a compound that denatures bacterial proteins.

Target Products:

  • Mandelamine (Methenamine Mandelate)
  
Trimethoprim
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by blocking the action of bacterial dihydrofolate reductase.

Buyer Products:

  • Proloprim (Trimethoprim) Tablets
  
Protozoal  
Antiprotozoal Agents  
Narrow Spectrum  
Amebiasis  
Aminoglycosides
Therapeutics that treat infections by an amoeba by inhibiting protozoal protein synthesis.

Buyer Products:

  • Humatin (Paramomycin Sulfate)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.

Target Products:

  • TD1414 (Topical Antibiotic)
  
Viral  
DNA Viruses  
Herpesvirus  
Herpes Simplex Type 1  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA blocking the action of an essential enzyme.

Buyer Products:

  • Viroptic Ophthalmic Solution (Trifluridine)
  
Herpes Simplex Type 2  
Viral DNA Polymerase Inhibitors
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by blocking the action of an essential enzyme.

Buyer Products:

  • Viroptic Ophthalmic Solution (Trifluridine)
  
Musculoskeletal System
Skeletal Disorders
Bone Disorders
Osteoporosis
Hormonal Treatments
Estrogens
Therapeutics that treat osteoporosis by providing female hormones which results in a decrease in the rate of bone loss due to osteoclasts.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)

Target Products:

  • Estrace Tablet (Estradiol)
Neurology
Neurological Disorders  
Epilepsy  
Status Epilepticus  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat status epilepticus by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Vanquix (Diazepam Auto-Injection)
  
Neuromuscular Disorders  
Parkinson`s Disease (PD)  
Adjunctive Treatments  
Cholinergic Receptor Blocking Agents
Therapeutics that assist in the treatment of the disorder involving nerve cell loss in portions of the brain that leads to uncontrolled tremors, abnormal posture and speech problems by blocking acetylcholine receptors on neurons.

Buyer Products:

  • Kemadrin (Procyclidine Hydrochloride)
  
Psychiatric Disorders
Mood Disorders  
Premenstrual Dysphoric Disorders  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat premenstrual dysphoric disorders by selectively preventing the removal of serotonin.

Target Products:

  • Sarafem (Fluoxetine Hydrochloride)
  
Sleep Disorders  
Insomnia  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Buyer Products:

  • Sonata CIV (Zaleplon)
  
Obstetrics/Gynecology
Child Birth/Pregnancy
Induction/Cervical Ripening  
Oxytocic Agents
Therapeutics that induce contractions by increasing the levels of intracellular calcium in the uterine smooth muscle thus mimicking uterine contractions and transiently impeding uterine blood flow.

Buyer Products:

  • Pitocin (Oxytocin)
  
Prenatal/Postnatal Nutrition  
Multivitamins
Therapeutics that supplement the nutritional needs of women during pregnancy.

Target Products:

  • NataFort
  • NataChew
  
Prevention (Contraception)  
Contraceptives (Birth Control)  
Estrogens/Progestins
Therapeutics that prevent conception by decreasing the secretion of gonadotropin-releasing hormone in the hypothalamus, resulting in an anti-ovulatory effect.

Target Products:

  • WC3016
  • FEMCON Fe (Norethindrone/Ethinyl Estradiol/Ferrous Fumarate)
  • Estrostep Fe (Norethindrone Acetate/Ethinyl Estradiol)
  • Ovcon 35/Ovcon 50 (Norethindrone/Ethinyl Estradiol)
  • Loestrin 24 Fe (Norethindrone Acetate/Ethinyl Estradiol)
  
Female Genital Disorders
Ovarian  
Hypogonadism  
Hormonal Treatments  
Estrogens
These are female sex hormones.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  • Menest (Esterified Estrogens Tablets)
  
Vulvovaginal
Atrophy
Hormonal Treatments
Estrogens
Therapeutics that treat disorders characterized by thinning of the vaginal walls with the female sex hormone estrogen.

Buyer Products:

  • Delestrogen (Estradiol Valerate Injection, USP)
  • Menest (Esterified Estrogens Tablets)

Target Products:

  • Estrace Tablet (Estradiol)
  • Femring (Estradiol Acetate Vaginal Ring)
  • Estrace Cream (17-Beta Estradiol)
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of female reproductive disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)

Target Products:

  • WC2061
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of female reproductive disorders in very early stages of research where no human subject is involved.

Target Products:

  • GD1105 (Vaginal Ring)
  
Oncology
Breast Cancer
Palliative Agents
Hormonal Treatments
Estrogens
Therapeutics that treat and manage breast cancer in post-menopausal women by providing female hormones.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)

Target Products:

  • Estrace Tablet (Estradiol)
Urology
Prostate Cancer
Palliative Agents
Estrogens
Therapeutics that treat and manage prostate cancer by inhibiting the secretion of luteinizing hormone and affecting the testes so as to decrease serum concentrations of testosterone but are not curative.

Buyer Products:

  • Menest (Esterified Estrogens Tablets)

Target Products:

  • Estrace Tablet (Estradiol)
Ophthalmology  
Degenerative Disorders  
Irritation/Inflammation  
Antibacterial Agents (Antibiotics)
Therapeutics that treat infections by inhibiting bacterial replication.

Buyer Products:

  • Polysporin (Bacitracin Zinc/Polymyxin B Sulfate)
  • Neosporin Ophthalmic (Neomycin Sulfate B/Polymyxin Sulfate B/Gramicidin) Ointment/Solution Sterile
  
Antibacterial Agents/Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat infections by inhibiting bacterial replication as well as prevent cells that cause inflammation from adhering to the inflammation site.

Buyer Products:

  • Cortisporin Opthalmic (Neomycin/Polymyxin B Sulfates/Bacitracin Zinc/Hydrocortisone) Ointment/Suspension Sterile
  
Pain Management  
Anesthesia  
General (Systemic)  
Adjunctive  
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.

Buyer Products:

  • Ketalar CIII (Ketamine Hydrochloride)
  
Barbiturates
Therapeutics that result in anesthesia due to a general sedative effect by enhancing the response to gamma aminobutyric acid and decrease excitability by directly suppressing conduction in the brain.

Buyer Products:

  • Brevital Sodium C-IV (Methohexital Sodium)
  
Primary  
Barbiturates
Therapeutics that result in anesthesia due to a general sedative effect by enhancing the response to gamma aminobutyric acid and decrease excitability by directly suppressing conduction in the brain.

Buyer Products:

  • Brevital Sodium C-IV (Methohexital Sodium)
  
Narcotics  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Avinza (Morphine Sulfate ER Capsules)
  • Remoxy (Time-Release Oxycodone)
  
Non-Narcotics  
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.

Buyer Products:

  • Skelaxin (Metaxalone)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of pain in early stages of clinical research where human subject is involved.

Buyer Products:

  • PTI-202
  • T-62
  
Respiratory System  
Lower Respiratory Tract Disorders (Lung Disorders)  
Asthma  
Acute Treatments  
Bronchodilators  
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in dilating the blood vessels in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Prophylactic Treatments  
Mast Cell Stabilizers
Therapeutics that treat asthma by inhibiting mast cell degranulation.

Buyer Products:

  • Tilade (Nedocromil Sodium)
  • Intal HFA (Cromolyn Sodium)
  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Bronchitis  
Complications  
Bacterial Infections  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Septra (Sulfamethoxazole/Trimethoprim) IV Infusion/Tablets/Suspension
  
Prophylactic Treatments  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Bronchospasm  
Bronchodilators  
Alpha Adrenergic Receptor Agonists/Beta Adrenergic Receptor Agonists
Therapeutics that cause dilation of the lung passages by supporting the actions of the adrenergic transmitters like epinephrine and norepinephrine.

Buyer Products:

  • Adrenalin Chloride Solution (Epinephrine)
  
Emphysema  
Prophylactic Treatments  
Phosphodiesterase Inhibitors (PDE Inhibitors)
Therapeutics that inhibit the break down of phosphodiesters thereby increasing levels of Nitric Oxide which help in relaxing smooth muscles in the lungs.

Buyer Products:

  • Quibron-T / Quibron-T/SR (Theophylline - Accudose)
  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Anticholinergic Agents/Opioids
Therapeutics that treat coughs and colds by relieving pain and fever as well as suppressing cough.

Buyer Products:

  • Tussigon Tablets CIII (Hydrocodone Bitartrate/Homatropine Methylbromide)
  
Decongestants/Antitussives
Therapeutics that treat coughs and colds by reducing mucous build up and suppressing the cough.

Buyer Products:

  • Nucofed Capsules/Syrup CIII (Codeine Phosphate/Pseudoephedrine Hydrochloride)
  
Decongestants/Antitussives/Expectorants
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing coughs and helping in the ejection of the mucous.

Buyer Products:

  • Nucofed Expectorant/Pediatric Expectorant (Codeine Phosphate/Pseudoephedrine Hydrochloride/Guaifenesin)
  
Surgery  
General  
Complications  
Hemorrhage  
Coagulating Agents (Coagulants)
Therapeutics that treat bleeding during a surgical procedure by promoting blood clotting.

Buyer Products:

  • Thrombin JMI
  
Toxicology  
Chemical Poisoning  
Nerve Gas  
Anticholinergic Agents
Therapeutics that treat toxicity due to nerve agent/gas by antagonizing the muscarine-like actions of acetylcholine and other choline esters.

Buyer Products:

  • AtroPen (Atropine)
  • Meridian Medical Technologies Duodote (Atropine/Pralidoxime Chloride Injection)
  
Urology
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of urological disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Bremelanotide/PT-141 (Alpha Melanocyte-Stimulating Hormone Analog)
  
Urological Disorders
Kidney (Renal)  
Chronic Renal Failure (CRF)  
Complications  
Edema  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Thalitone (Chlorthalidone)
  
Renal Insufficiency  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that delay or treat kidney disease by inhibiting the renin-angiotensin system.

Buyer Products:

  • Altace (Ramipril)
  
Urinary Tract Pain  
Analgesics
Therapeutics that alleviate pain from infections of the urinary tract.

Target Products:

  • Pyridium/Pyridium Plus (Phenazopyridine Hydrochloride)
  
Wound Management  
Burns  
Complications  
Infections  
Antibacterial Agents (Antibiotics)  
Sulfonamides
Therapeutics that treat bacterial infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Antifungal Agents  
Sulfonamides
Therapeutics that treat fungal infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silvadene (Silver Sulfadiazine)
  
Medical Devices  
Cardiology  
Diagnostic  
Monitoring  
Monitors  
Electrocardiogram (ECG/EKG)  
Interpretive/Analysis
Specialized electrocardiogram devices that facilitate certain diagnostic functions and analysis.

Buyer Products:

  • Meridian Medical Technologies Prime ECG Electrocardiac Mapping System
  
Stress/Exercise Test
Instruments used to evaluate the cardiopulmonary system during exercise.

Buyer Products:

  • Binodenoson
  
Telemetry  
Telemetry Systems
Complete systems or devices used to facilitate transfer of vitals monitoring data from the patient's site to a central monitor.

Buyer Products:

  • Meridian Medical Technologies Transtelephonic Blood Pressure Monitors
  • Meridian Medical Technologies CardioBeepers
  
Clinical Diagnostics  
Immunoassays  
Reagents  
Test Kits  
Bacterial  
Tuberculosis
Immunoassay test kits which quantitatively measure tuberculosis antibody in plasma or serum.

Buyer Products:

  • Aplisol (Tuberculin Purified Protein Derivative)
  
Drug Delivery  
Percutaneous (Subcutaneous/Intramuscular/Intravenous)  
Automatic Injectors
Pen-shaped medical devices used to contain and deliver liquid medications to a specified needle depth with a press of a button.

Buyer Products:

  • Meridian Medical Technologies Auto-Injector Technology
  
General Surgery  
Invasive  
Surgical-Site Treatments  
Sealants  
Hemostatic  
Topical
Topical mixture used when conventional hemostasis procedures are not effective.

Buyer Products:

  • Thrombix
  • ThrombiGel
  
Radiology  
Nuclear  
Gamma Camera  
Contrast Agents  
Radionuclides  
Adjuncts
Radioactive materials that are introduced to the body for nuclear imaging purposes.

Buyer Products:

  • Adenoscan
 
Outsourced Services  
Development/Manufacturing Services  
Chemistry Services
Outsourced companies that provide medicinal chemistry, organic synthesis, process research, cGMP synthesis, and analytical services to the biopharmaceutical industry.

Buyer Products:

  • Meridian Medical Technologies Contract Development Services
  
Contract Manufacturing Organizations (CMO)  
Medical Devices
Contract Manufacturing Organizations that manufacture (and/or design, develop) medical devices and products for other organizations.

Buyer Products:

  • Meridian Medical Technologies Contract Manufacturing Services
  
Pharmaceuticals  
Active/Intermediate Chemicals
Intermediate and active ingredient contract manufacturing organizations that produce large quantities of small molecule compounds for use in final dosage forms.

Buyer Products:

  • Meridian Medical Technologies Contract Manufacturing Services
  • King Pharmaceuticals Contract Manufacturing Services
  
Biologics
Active Ingredient Contract Manufacturing Organizations (CMO) that manufacture antibodies, proteins, and genetic materials.

Buyer Products:

  • King Pharmaceuticals Contract Manufacturing Services
  
Manufacturing  
Consumer Manufacturing  
Personal Care and Cleaning Products  
Skin Care
Companies engaged in the manufacturing of skin care products, such as suntan lotion, skin lotion, sanitizer, shaving cream, and moisturizer. Also includes manufacturers of non-electrical shaving equipment.

Target Products:

  • Moisturel
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Bradley Pharmaceuticals, Inc. n/a 349.106 29.12 30.04 2.36 2.26 176.67
Buyer
  Shire plc (ADR) n/a 13,905.893 42.17 38.08 7.27 6.37 7.16
Endo Pharmaceuticals n/a 4,554.984 26.11 20.01 4.75 4.39 5.41
Biovail Corporation (USA) n/a 4,214.661 17.78 13.95 3.86 4.83 7.54
Valeant Pharmaceuticals International n/a 1,673.372 n/a 24.07 1.82 1.78 n/a
Alpharma Inc. n/a 1,126.802 18.45 19.86 1.70 1.60 2.44
Cubist Pharmaceuticals, Inc. n/a 1,087.448 97.93 28.29 5.08 4.00 40.94
ZymoGenetics, Inc. n/a 950.791 n/a -7.03 41.03 22.60 4.50
Sciele Pharma Inc. n/a 852.988 17.37 14.71 2.76 2.29 8.11
Impax Laboratories Inc. n/a 701.817 600.78 12.69 6.23 n/a 11.96
Omrix Biopharmaceuticals, Inc. n/a 567.644 24.46 33.67 8.52 9.93 5.29
Vanda Pharmaceuticals Inc. n/a 563.480 n/a -5.30 n/a 28.06 4.44
ACADIA Pharmaceuticals Inc. n/a 505.146 n/a -8.12 66.86 47.79 8.89
Neurocrine Biosciences, Inc. n/a 451.297 n/a -3.91 22.72 79.15 1.55
Target
  Johnson & Johnson n/a 183,728.685 17.80 15.68 3.32 3.03 15.71
Wyeth n/a 76,445.442 17.65 16.28 3.66 3.52 7.12
Bayer AG (ADR) n/a 59,496.370 11.48 17.19 1.47 1.35 n/a
Novo Nordisk A/S (ADR) n/a 37,284.626 29.67 22.18 5.21 5.04 7.10
Akzo Nobel N.V. (ADR) n/a 25,181.940 16.26 18.32 1.37 1.70 5.42
Barr Pharmaceuticals, Inc. n/a 5,703.635 n/a 16.95 3.05 2.29 n/a
Medicis Pharmaceutical Corporation n/a 1,736.744 79.01 26.85 4.70 3.84 5.69
Bradley Pharmaceuticals, Inc. n/a 349.106 29.12 30.04 2.36 2.26 176.67
CollaGenex Pharmaceutical, Inc n/a 272.852 n/a -15.14 7.39 4.34 4.75
Galderma SA n/a n/a n/a n/a n/a n/a n/a
Stiefel Laboratories, Inc. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  sanofi-aventis (ADR) n/a 115,606.307 21.13 11.84 2.87 2.96 n/a
Harte-Hanks, Inc. n/a 1,939.135 17.90 18.81 1.63 1.58 n/a
Allscripts Healthcare Solutions, Inc. n/a 1,383.353 91.98 45.76 5.52 4.53 28.58
Pain Therapeutics, Inc. n/a 393.417 21.92 33.85 6.49 6.03 4.32
Palatin Technologies, Inc. n/a 166.458 n/a -4.95 9.94 10.39 6.90
Vascular Solutions, Inc. n/a 149.103 n/a -31.10 3.28 2.82 16.35
DepoMed, Inc. n/a 104.434 n/a -2.66 8.68 4.18 n/a
Gelita AG n/a n/a n/a n/a n/a n/a n/a
Target
  Bristol Myers Squibb Co. n/a 63,096.168 40.42 22.55 3.56 3.22 17.26
Barr Pharmaceuticals, Inc. n/a 5,703.635 n/a 16.95 3.05 2.29 n/a
LEO Pharma A/S n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  McKesson Corporation 32.00% 17,962.263 19.67 18.67 0.19 0.18 5.74
Cardinal Health, Inc. 29.00% 27,060.021 20.05 20.60 0.31 0.31 7.82
AmerisourceBergen Corp. 13.00% 9,584.657 19.44 19.49 0.15 0.15 6.89
Buyer
  McKesson Corporation 32.00% 17,962.263 19.67 18.67 0.19 0.18 5.74
Cardinal Health, Inc. 29.00% 27,060.021 20.05 20.60 0.31 0.31 7.82
AmerisourceBergen Corp. 13.00% 9,584.657 19.44 19.49 0.15 0.15 6.89
Salix Pharmaceuticals, Ltd. n/a 614.521 20.02 14.94 2.71 2.30 7.89
QLT Inc. (USA) n/a 538.030 n/a 23.77 3.42 3.96 2.52
Vascular Solutions, Inc. n/a 149.103 n/a -31.10 3.28 2.82 16.35
Government - United States n/a n/a n/a n/a n/a n/a n/a
Merck KGaA n/a n/a n/a n/a n/a n/a n/a
Target
  McKesson Corporation 36.00% 17,962.263 19.67 18.67 0.19 0.18 5.74
Cardinal Health, Inc. 30.00% 27,060.021 20.05 20.60 0.31 0.31 7.82
AmerisourceBergen Corp. 11.00% 9,584.657 19.44 19.49 0.15 0.15 6.89
CVS Caremark Corporation 10.00% 56,871.768 39.65 19.22 1.21 0.75 25.93

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Barr Pharmaceuticals, Inc. n/a 5,703.635 n/a 16.95 3.05 2.29 n/a
Buyer
  sanofi-aventis (ADR) n/a 115,606.307 21.13 11.84 2.87 2.96 n/a
Wyeth n/a 76,445.442 17.65 16.28 3.66 3.52 7.12
Eli Lilly & Co. n/a 64,549.724 27.63 16.80 3.98 3.63 7.08
Barr Pharmaceuticals, Inc. n/a 5,703.635 n/a 16.95 3.05 2.29 n/a
Arrow International, Inc. n/a 1,754.017 28.71 29.23 3.45 3.40 3.71
Salix Pharmaceuticals, Ltd. n/a 614.521 20.02 14.94 2.71 2.30 7.89
QLT Inc. (USA) n/a 538.030 n/a 23.77 3.42 3.96 2.52
Pain Therapeutics, Inc. n/a 393.417 21.92 33.85 6.49 6.03 4.32
Palatin Technologies, Inc. n/a 166.458 n/a -4.95 9.94 10.39 6.90
Vascular Solutions, Inc. n/a 149.103 n/a -31.10 3.28 2.82 16.35
Target
  Bristol Myers Squibb Co. n/a 63,096.168 40.42 22.55 3.56 3.22 17.26
Bayer AG (ADR) n/a 59,496.370 11.48 17.19 1.47 1.35 n/a
CVS Caremark Corporation n/a 56,871.768 39.65 19.22 1.21 0.75 25.93
Cardinal Health, Inc. n/a 27,060.021 20.05 20.60 0.31 0.31 7.82
McKesson Corporation n/a 17,962.263 19.67 18.67 0.19 0.18 5.74
AmerisourceBergen Corp. n/a 9,584.657 19.44 19.49 0.15 0.15 6.89
Barr Pharmaceuticals, Inc. n/a 5,703.635 n/a 16.95 3.05 2.29 n/a
Watson Pharmaceuticals, Inc. n/a 3,387.591 n/a 26.26 1.51 1.32 32.91
Contract Pharmaceuticals Limited n/a n/a n/a n/a n/a n/a n/a
Pharmaceutics International, Inc. n/a n/a n/a n/a n/a n/a n/a
Paratek Pharmaceuticals, Inc. n/a n/a n/a n/a n/a n/a n/a
LEO Pharma A/S n/a n/a n/a n/a n/a n/a n/a
Foamix Ltd. n/a n/a n/a n/a n/a n/a n/a
Mayne Pharma Limited n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 2,020.3 801.6 2,821.9
Other Revenue 0.0 4.8 4.8
Total Revenue 2,020.3 806.4 2,826.7
Cost of Revenue 438.9 170.5 609.4
SG&A Expense 671.2 293.5 964.7
Depreciation & Amortization 148.9 252.2 401.0
Research & Development 146.0 24.7 170.7
Interest Expense 0.0 192.8 192.8
Other Operating Expense 0.0 17.5 17.5
Unusual Expense (Income) 117.7 0.0 117.7
Total Expenses 1,522.5 951.3 2,473.8
Operating Income 497.8 -144.8 352.9
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng 26.6 0.0 26.6
Other, Net -1.2 0.0 -1.2
Income Before Taxes 523.1 -144.8 378.3
Income Taxes 169.3 -14.1 155.3
Income After Taxes 353.8 -130.8 223.0
Net Income - Excl. Xord. Items 353.8 -130.8 223.0
Discontinued Operations 0.4 0.0 0.4
Net Income - Incl. Xord. Items 354.2 -130.8 223.4
Preferred Dividends 0.0 -43.3 -43.3
Income Avail. to Common 354.2 -174.0 180.2
Share Items
Basic Avg. Shares Outstanding 242.4 248.6 491.0
Basic EPS - Excl. Xord. Items 1.46 n/a 0.45
Basic EPS - Incl. Xord. Items 1.46 n/a 0.46
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 243.7 248.6 492.3
F.D. EPS - Excl. Xord. Items 1.45 n/a 0.45
F.D. EPS - Incl. Xord. Items 1.45 n/a 0.45
Balance Sheet
Assets
Cash and Equivalents 60.2 68.5 128.7
ST Investments 758.2 0.0 758.2
Accounts Receivable 263.5 74.3 337.9
Inventory 207.9 68.9 276.8
Prepayments and Advances 48.3 88.6 136.9
Other Current Assets 61.2 0.0 61.2
Current Assets 1,399.3 300.3 1,699.6
Accum D&A 0.0 0.0 0.0
PPE, Net 306.7 49.2 355.9
Goodwill & Intangibles 1,236.9 2,727.6 3,964.5
Long Term Investments 10.5 0.0 10.5
Other Assets 0.0 0.0 0.0
Other LT Assets 380.1 42.5 422.6
Total Assets 3,333.5 3,119.6 6,453.1
Liabilities
Accounts Payable 67.1 27.7 94.8
Payable/Accrued 0.0 0.0 0.0
Accrued Expenses 353.7 140.3 494.0
ST Debt 0.0 0.0 0.0
Curr Port of LTD & Cap Lease Oblg 0.0 11.2 11.2
Other (Current) Liabilities 44.2 0.0 44.2
Current Liab. 465.0 179.2 644.2
LT Debt 400.0 1,476.6 1,876.6
Total LT Debt 400.0 1,476.6 1,876.6
Other LT Liab. 58.8 140.6 199.4
Total Liabilities 923.8 1,796.5 2,720.2
Shareholders Equity
Common Stock 1,252.1 2.5 1,254.6
Additional Paid in Capital 0.0 2,042.6 2,042.6
Retained Earnings 1,158.3 -714.9 443.4
Treasure Stock 0.0 -6.3 -6.3
Other Equity -0.7 -0.8 -1.4
Total Equity 2,409.7 1,323.1 3,732.8
Total Liab. & Equity 3,333.5 3,119.6 6,453.1
Shares Outstanding 243.5 250.6 494.1
Cash Flow
Operating Cash Flow
CF Net Income 0.0 -130.8 -130.8
CF Depreciation 0.0 7.9 7.9
CF Amortization 0.0 252.2 252.2
CF Deferred Taxes 0.0 -16.0 -16.0
Other Non-Cash Items 0.0 66.8 66.8
Change in Working Capital 579.3 -21.1 558.2
Total Cash From Operating Activities 579.3 159.0 738.3
Investing Cash Flow (not calculated)
Capital Expenditures -57.2 -16.1 -73.2
Other Investing Cash Flows -614.5 -28.8 -643.3
Total Cash From Investing Activities -671.6 -44.9 -716.5
Financing Cash Flow (not calculated)
Dividends Paid 0.0 0.0 0.0
Purchase Or Sale of Stock 3.3 999.4 1,002.7
Purchase and Retirement of Debt -179.3 -738.2 -917.5
Other Financing Cash Flow 0.2 -327.6 -327.4
Total Cash From Financing Activities -175.8 -66.4 -242.2
Exchange Rate Effects 0.0 0.0 0.0
Net Change in Cash -268.1 47.7 -220.4
Cash Taxes Paid 163.9 6.6 170.5
Cash Interest Paid 8.2 190.0 198.2